title: ACCF and AHA Release Guidelines on the Management of Heart Failure.
abstract: Treatment of stage A heart failure should focus on reducing modifiable risk factors, including management of hypertension and hyperlipidemia. To prevent symptomatic heart failure, ACE inhibitors and beta blockers should be used in all patients with stage B or C heart failure who have a reduced ejection fraction. Patients with stage C heart failure and fluid retention should be treated with diuretics in addition to ACE inhibitors and beta blockers.
authors: Carrie
authors: C
authors: Armstrong
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000572:American Heart Association / Q000458:organization & administration; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002309:Cardiology / Q000458:organization & administration; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D006949:Hyperlipidemias / Q000175:diagnosis / Q000188:drug therapy*; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy*; D014481:United States
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics